FDAnews Drug Daily Bulletin

UCB SAYS INTERESTED IN ELI LILLY'S BELGIAN R&D SITE

July 5, 2006
A A

Belgian pharmaceutical company UCB SA said Monday it may be interested in Eli Lilly & Co.'s (LLY) research and development center at Mont-Saint-Guibert in Belgium.
Easy Bourse